Skip to main content
High RiskFDAfda-F-1249-2013UNDECLARED ALLERGEN

Ruthies Cranberry Orange Breakfast Cookie, individually wrapped in plastic, net wt. 4.9 oz. The product is labeled in parts: "***Ruthi...

Category
Units Affected
30
Recall Date
February 21, 2013
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1249-2013.

Ruthies Cranberry Orange Breakfast Cookie is recalled because butter (cream) is declared but milk is NOT declared on label.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1249-2013.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Wholesale Baking, Inc. or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1249-2013.

Wholesale Baking, Inc.

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Wholesale Baking, Inc. Recall FAQ

Wholesale Baking, Inc. is the subject of a dairy safety report: Ruthies Cranberry Orange Breakfast Cookie, individually wrapped in plastic, net wt. 4.9 oz. The product is labeled in parts: "***Ruthi.... The notice was published on February 21, 2013 by the U.S. Food and Drug Administration (FDA). Approximately 30 units are potentially affected.